Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Sof-Genotype'
Sof-Genotype published presentations and documents on DocSlides.
SOF/VEL 400/100 mg qd N = 75
by danika-pritchard
W24. SOF/VEL. >. 18 years. Chronic HCV infect...
SOF + EBR + GZR + RBV
by test
N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...
Safety and Efficacy of Daclatasvir
by tabitha
. Plus . Sofosbuvir. With or Without Ribavirin . ...
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
MEF Modeling Activities Putting Models in Context
by natalie
Outline. Challenges. MEF’s . Third Network Visio...
The Paradox of Highly Effective
by Kingslayer
Sofosbuvir. . Combo Therapy . Despite . Slow . He...
Treatment of Chronic HCV
by lam
with Direct-Acting Antivirals (DAAs). www.hcvguide...
Slides for today’s webinar are available on the CIHS website at:
by tatiana-dople
Slides for today’s webinar are available on the...
Success through Skype Operations Framework
by calandra-battersby
Srini Raghavan . Ali Rohani. BRK2077. What does i...
Ledipasvir-Sofosbuvir ( Harvoni
by sherrill-nordquist
). Slide deck prepared . by: . David H. Spach, MD...
Simplified HCV Therapy in 2018
by phoebe-click
This program is s. upported. by educational gran...
Senior Leader Panel HQ Air Force Special Operations Command / FM
by tatyana-admore
1. AFSOC Basics. Mission. : . Organize. , train ...
ARSOF WARFIGHTING CHALLENGES
by min-jolicoeur
Enduring ARSOF First Order Problems, the Solution...
1 Briefing Graphics & Unit Symbols,
by phoebe-click
Wargaming Div, MCWL, Quantico. Updated 10 Jan 20...
ALLY-2
by aaron
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
ALLY-2
by tawny-fly
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
Sofosbuvir, Ribavirin, GS
by min-jolicoeur
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
ION-4
by briana-ranney
Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Mr. John A. Wilcox
by sherrill-nordquist
Director, J6/CIO . United States Special Operatio...
1 SOCOM
by pamella-moone
Acquisition Perspective . to. . NDIA. James W. C...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
MEF Common Information Model Overview
by adia
Jessie Jewitt. Modeling in the MEF. 4 Types of Mod...
Why 145Buy or Build146 Wrong QuestionIs it better to buy your core sof
by jalin
executiveinsightsContentsThe limitations of buildi...
Chefsof the day
by brianna
Served with mashed potatoes with gravy andView our...
Use of HCV DAAs with HIV Regimens
by robaut
Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....
RX TX E LINK @ 80 Mbps
by relievinglexus
Request. Reply. Master (CRU FPGA). Slave (SCA). Ma...
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
HIV Pipeline Cabotegravir-LA
by liane-varnes
(GSK-744; CAB). For . PrEP. INI. ViiV. Topical mi...
Hepatitis C: A New Era In Treatment And Cure
by myesha-ticknor
Adam . Deising. , DO. LCDR MC USN. Director of . ...
Description of Antivirals for Hepatitis C
by conchita-marotz
LCDR Dwayne David, . PharmD. , BCPS, NCPS. Cherok...
Community Pharmacy Considerations for HIV
by tawny-fly
& HCV . Therapy. Larry Pineda, . PharmD. , . ...
Use the Web Browser on Your Mobile Device to Participate in Polling*
by phoebe-click
Go to: pollev.com/CCO2. or scan the QR code below...
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Prevention strategies for HIV/HCV co infection
by giovanna-bartolotta
Isabelle Andrieux-Meyer, MD. Médecins Sans Front...
Opportunities & Challenges:
by pasty-toler
Expanding Access to Hepatitis C Treatment . Gregg...
Updated Guidelines for Managing HIV/HCV Co-Infection
by karlyn-bohler
John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...
HIV Pipeline Doravirine 2
by giovanna-bartolotta
(MK-1439; DOR). . NNRTI. Merck. Filed with USFDA...
Load More...